• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Research

Jennifer Doudna arriving at the laureates Get together at the Nobel Prize Museum in Stockholm on 6 December 2022
Research

Nobel Laureate Jennifer Doudna enters AI protein design arena

In a new paper, Doudna’s team described a new platform for generating novel gene editing enzymes.
Darren Incorvaia Jul 16, 2026 2:00pm
doctor taking umbilical cord from tube

Axiom hopes it ‘solved 2 major potholes’ for stem cell biotechs

Jul 16, 2026 10:40am
Ebola Ebola test

First Bundibugyo Ebola vaccine to enter phase 1 trials

Jul 14, 2026 12:18pm
Company logo on the outside of a building at the EMD Serono Research  Development Institute in Billerica Massachusetts

Merck KGaA in-office requirement could lead to 70 US layoffs

Jul 13, 2026 2:32pm
Hand with tweezers editing DNA

ARPA-H awards up to $160M for custom genetic medicines

Jul 10, 2026 4:00am
computer and clinical science AI data

Fate’s CAR-T prospect shows early promise in systemic sclerosis

Jul 9, 2026 10:24am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings